Lv6
1790 积分 2024-07-06 加入
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
2个月前
已完结
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
2个月前
已完结
Treating early-stage myelofibrosis
3个月前
已完结
Acute Leukaemias with TEL/ABL Fusion: a Subgroup with Poor Prognosis and Prenatal Origin
5个月前
已关闭
Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin
5个月前
已完结
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
6个月前
已完结
Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document
6个月前
已完结
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy
6个月前
已完结
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
6个月前
已完结
High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy
7个月前
已完结
皖公网安备34019202002308
